{"@id":"https://bioecon.ru/technology/viral-vectored-neoantigen-vaccines/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://cn.bioecon.ru/technology/viral-vectored-neoantigen-vaccines/","json":"https://cn.bioecon.ru/api/v1/technology/viral-vectored-neoantigen-vaccines/index.json"},"id":"viral-vectored-neoantigen-vaccines","industries":["pharma","biomanufacturing"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/genscript-probio-genscript/","https://bioecon.ru/companies/agc-biologics/","https://bioecon.ru/companies/vaksindo-animal-health/","https://bioecon.ru/companies/esco-aster/","https://bioecon.ru/companies/vaxxinova-norway/","https://bioecon.ru/companies/ridgeway-biologicals/","https://bioecon.ru/companies/gsk/"]},"maturity":7,"name":"病毒载体搭载个体化肿瘤新抗原治疗性疫苗","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"个体化肿瘤体细胞新抗原算法预测"},{"n":2,"title":"多表位串联人工长肽表达盒设计"},{"n":3,"title":"非人源复制缺陷型重组病毒载体包装"},{"n":4,"title":"异源初免-加强方案诱导极高频效应T细胞"}],"summary":"基于无预存免疫力的黑猩猩腺病毒（ChAd）与改良安卡拉痘苗病毒（MVA）异源初免-加强疫苗平台，搭载计算预测的数十个高亲和力患者自体肿瘤新抗原串联表位，诱发超高频多功能CD8+与CD4+记忆T细胞应答。","url":"/technology/viral-vectored-neoantigen-vaccines/","verified":"2026-11-22"}